MedTrace Logo

Group Cognitive Behavioral Therapy for IBD Patients

NCT03667586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2022-06-02

No results posted yet for this study

Summary

Inflammatory bowel disease (IBD) patients commonly suffer from disturbed psychosocial functioning and poor quality of life compared to other chronic disease patients. Clinicians are becoming growingly aware that addressing patients' psychological difficulties may improve disease management, however, there is not adequate evidence regarding the effect of psychotherapeutic interventions on psychosocial functioning and disease-related clinical and laboratory parameters. The aim of the present study is the evaluation of the effects of a targeted, cognitive behavioral psychotherapeutic intervention on symptom severity, levels of psychological distress and quality of life and inflammation and disease activity indices in IBD patients. An additional aim is the detection of psychological and biomedical parameters which may be associated with these effects.

Conditions

  • Inflammatory Bowel Diseases

Interventions

BEHAVIORAL

Group cognitive behavioral therapy

Group sessions based on the principles of Cognitive Behavioral Therapy and adjusted for chronic disease patients

Sponsors & Collaborators

  • University Hospital of Patras

    lead OTHER

Principal Investigators

  • Christos Triantos, PhD · University of Patras, Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-21
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667586 on ClinicalTrials.gov